David Malcom Rodman sold $59K of MLYS stock

David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS), sold 2,170 shares of MLYS stock worth $59K, per an SEC Form 4 filed Aug 12, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 10, 2026, 2 days before it was made public.

MLYS has moved -44.0% since the trade date, from $27.38 to $15.33 (Nov 6, 2026 close).